Michael Catelani, President, COO, & CFO at Anixa Biosciences Inc (ANIX), bought 6,250 shares at $2.40 ($15K) on 2024-06-07, disclosed to the SEC on 2024-06-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| ANIX | BUY | 2023-07-21 | $20K | — | Filing → |
| ANIX | BUY | 2022-04-22 | $15K | — | Filing → |
| ANIX | BUY | 2022-04-21 | $6K | — | Filing → |